CNS Pharmaceuticals

CNSP33

Penny Stock

$0.10arrow_drop_down4.87%-$0.00

Penny Stock

CNSP33

$0.10

arrow_drop_down4.87%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.11
Prev. Close	$0.11
EPS	-352.97
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$4.28M
PE Ratio	-

	LOW	HIGH
Day Range	0.10	0.11
52 Week Range	0.09	12.74

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-352.97

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About CNS Pharmaceuticals (CNSP)

CNS Pharmaceuticals Inc (CNSP) is a pharmaceutical company that focuses on the development and commercialization of novel medicines for the treatment of cancer. The company's primary focus is on developing therapies for the treatment of brain tumors, specifically glioblastoma multiforme (GBM), a highly aggressive form of brain cancer. CNSP's goal is to provide innovative treatment options that can improve the prognosis and quality of life for patients with GBM.

The stock price history of CNS Pharmaceuticals Inc (CNSP) shows fluctuations over the years, reflecting the market's response to various factors such as clinical trial results, regulatory approvals, and overall market conditions. Investors should carefully consider these factors when evaluating the company's stock. It is important to note that past performance is not indicative of future results.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. John Michael Climaco Esq., J.D.
Headquarters: Houston
Employees: 3
Exchange: NASDAQ

Keep an eye on CNS Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is CNS Pharmaceuticals 's (CNSP) price per share?

The current price per share for CNS Pharmaceuticals (CNSP) is $0.11. The stock has seen a price change of -$0.01 recently, indicating a -4.88% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for CNS Pharmaceuticals (CNSP)?

For CNS Pharmaceuticals (CNSP), the 52-week high is $12.74, which is 12.03K% from the current price. The 52-week low is $0.1, the current price is 9.48% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is CNS Pharmaceuticals (CNSP) a growth stock?

CNS Pharmaceuticals (CNSP) has shown an average price growth of -6.65% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CNS Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is CNS Pharmaceuticals (CNSP) stock price performance year to date (YTD)?

As of the latest data, CNS Pharmaceuticals (CNSP) has a year-to-date price change of -99.82%. Over the past month, the stock has experienced a price change of -14.69%. Over the last three months, the change has been -20.68%. Over the past six months, the figure is -99.07%. Looking at a longer horizon, the five-year price change stands at -100%.

help

Is CNS Pharmaceuticals (CNSP) a profitable company?

CNS Pharmaceuticals (CNSP) has a net income of -$18.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$18.87M. Furthermore, the EBITDA is -$15.98M.

help

What is the market capitalization of CNS Pharmaceuticals (CNSP)?

CNS Pharmaceuticals (CNSP) has a market capitalization of $4.28M. The average daily trading volume is 0.11, indicating the stock's liquidity and investor engagement.